The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone® High-Dose...

Sanofi Pasteur, the vaccines division of Sanofi, announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza, or flu season have been released by the U.S. Food and...

By

Sanofi Pasteur announced last week that its first doses of Fluzone® (Influenza Vaccine) for the 2015-2016 influenza (“flu”) season have been released by the U.S. Food and Drug Administration...